-
公开(公告)号:WO02103026A2
公开(公告)日:2002-12-27
申请号:PCT/EP0205782
申请日:2002-05-27
Applicant: HOFFMANN LA ROCHE
Inventor: HOESS EVA , MEIER THOMAS , PESTLIN GABRIELE , POPP FRIEDRICH , REICHERT KLAUS , SCHMUCK RAINER , SCHNEIDINGER BERND , SEIDEL CHRISTOPH , TISCHER WILHELM
IPC: C12N15/09 , A61K38/00 , A61P31/12 , A61P31/18 , C07K14/155 , C07K14/16 , C12N1/21 , C12N15/62 , C12P21/02 , C12P21/00
CPC classification number: C07K14/005 , C07K2319/00 , C12N2740/15022 , C12N2740/16122 , C12P21/02
Abstract: A process for the production of an antifusogenic peptide of a length of about 10 to 50 amino acids in a prokaryotic host cell, characterized in that, under such conditions that inclusion bodies of said non-fusion antifusogenic peptide or said fusion peptide are formed, a) in said host cell there is expressed a nucleic acid encoding said antifusogenic peptide as a non-fusion peptide or encoding a fusion peptide of a length of about 14 to 70 amino acids consisting of said antifusogenic peptide N-terminally linked to a further peptide of a length of about 4 to 30 amino acids; b) said host cell is cultivated; c) said inclusion bodies are recovered and solubilized; d) in the case of said fusion peptide said antifusogenic peptide is cleaved off from said further peptide; and e) said antifusogenic peptide is isolated.
Abstract translation: 一种在原核宿主细胞中生产长度约10至50个氨基酸的抗融合肽的方法,其特征在于,在形成所述非融合抗融合肽或所述融合肽的包涵体的条件下, )在所述宿主细胞中表达编码所述抗融合肽作为非融合肽或编码长度约为14至70个氨基酸的融合肽的核酸,所述融合肽由所述抗融合肽组成,所述融合肽与N-末端连接的另一个肽 长度约4至30个氨基酸; b)培养宿主细胞; c)所述包涵体被回收和溶解; d)在所述融合肽的情况下,所述抗融合肽从所述另外的肽切除; 和e)分离所述抗融合肽。
-
公开(公告)号:WO2005040807A3
公开(公告)日:2005-06-16
申请号:PCT/EP2004011601
申请日:2004-10-15
Applicant: ROCHE DIAGNOSTICS GMBH , HOFFMANN LA ROCHE , PESTLIN GABRIELE , ANDRES HERBERT , BERNDT PETER , HAGMANN MARIE-LUISE , KARL JOHANN , LANGEN HANNO , ZOLG WERNER
Inventor: PESTLIN GABRIELE , ANDRES HERBERT , BERNDT PETER , HAGMANN MARIE-LUISE , KARL JOHANN , LANGEN HANNO , ZOLG WERNER
IPC: G01N33/574
CPC classification number: G01N33/57415
Abstract: The present invention relates to the diagnosis of breast cancer. It discloses the use of protein swiprosin-2 (SWS2) in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring SWS2 in said sample. Measurement of SWS2 can, e.g., be used in the early detection or diagnosis of breast cancer.
Abstract translation: 本发明涉及乳腺癌的诊断。 它公开了蛋白质Swiprosin-2(SWS2)在乳腺癌诊断中的应用。 本发明涉及一种通过测量所述样品中的SWS2从来自个体的液体样品诊断乳腺癌的方法。 SWS2的测量可以例如用于乳腺癌的早期检测或诊断。
-
3.
公开(公告)号:WO2005124360A3
公开(公告)日:2006-05-26
申请号:PCT/EP2005006526
申请日:2005-06-17
Applicant: ROCHE DIAGNOSTICS GMBH , HOFFMANN LA ROCHE , PESTLIN GABRIELE , ANDRES HERBERT , BERNDT PETER , HAGMANN MARIE-LUISE , KARL JOHANN , LANGEN HANNO , THIEROLF MICHAEL , ZOLG WERNER
Inventor: PESTLIN GABRIELE , ANDRES HERBERT , BERNDT PETER , HAGMANN MARIE-LUISE , KARL JOHANN , LANGEN HANNO , THIEROLF MICHAEL , ZOLG WERNER
IPC: G01N33/574 , G01N33/68
CPC classification number: G01N33/57415 , G01N2333/99
Abstract: The present invention relates to the diagnosis of breast cancer. It discloses the use of protein TEBP (telomerase-binding protein p23) in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring TEBP in said sample. Measurement of TEBP can, e.g., be used in the early detection or diagnosis of breast cancer.
Abstract translation: 本发明涉及乳腺癌的诊断。 它公开了蛋白TEBP(端粒酶结合蛋白p23)在乳腺癌诊断中的应用。 本发明涉及通过测定所述样品中的TEBP从个体得到的来自液体样品的乳腺癌诊断方法。 TEBP的测量可以例如用于乳腺癌的早期检测或诊断。
-
公开(公告)号:WO2006066917A2
公开(公告)日:2006-06-29
申请号:PCT/EP2005013869
申请日:2005-12-22
Applicant: ROCHE DIAGNOSTICS GMBH , HOFFMANN LA ROCHE , ANDRES HERBERT , HAGMANN MARIE-LUISE , KARL JOHANN , KUNERT URSULA , PESTLIN GABRIELE
Inventor: ANDRES HERBERT , HAGMANN MARIE-LUISE , KARL JOHANN , KUNERT URSULA , PESTLIN GABRIELE
IPC: G01N33/574
CPC classification number: G01N33/57419
Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein ASC (apoptosis-associated speck-like protein containing a caspaseassociated recruitment domain) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring ASC in said sample. Measurement of ASC can, e.g., be used in the early detection or diagnosis of colorectal cancer.
Abstract translation: 本发明涉及结肠直肠癌的诊断。 它公开了在结肠直肠癌诊断中使用蛋白质ASC(含有胱天蛋白酶相关募集域的凋亡相关斑点样蛋白)。 本发明涉及一种通过测量所述样品中ASC的来自个体的来自液体样品的结肠直肠癌的诊断方法。 ASC的测量可以例如用于结肠直肠癌的早期检测或诊断。
-
5.
公开(公告)号:WO2005124354A3
公开(公告)日:2006-05-18
申请号:PCT/EP2005006521
申请日:2005-06-17
Applicant: ROCHE DIAGNOSTICS GMBH , HOFFMANN LA ROCHE , PESTLIN GABRIELE , ANDRES HERBERT , BERNDT PETER , HAGMANN MARIE-LUISE , KARL JOHANN , LANGEN HANNO , THIEROLF MICHAEL , ZOLG WERNER
Inventor: PESTLIN GABRIELE , ANDRES HERBERT , BERNDT PETER , HAGMANN MARIE-LUISE , KARL JOHANN , LANGEN HANNO , THIEROLF MICHAEL , ZOLG WERNER
IPC: G01N33/574
CPC classification number: G01N33/57415
Abstract: The present invention relates to the diagnosis of breast cancer. It discloses the use of protein CH10 (human mitochondrial 10 kDa heat shock protein) in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring CH10 in said sample. Measurement of CH10 can, e.g., be used in the early detection or diagnosis of breast cancer.
Abstract translation: 本发明涉及乳腺癌的诊断。 它公开了蛋白质CH10(人类线粒体10 kDa热休克蛋白)在乳腺癌诊断中的应用。 本发明涉及通过在所述样品中测量CH10从个体得到的来自液体样品的乳腺癌诊断方法。 可以例如在乳腺癌的早期检测或诊断中使用CH 10的测量。
-
6.
公开(公告)号:WO2005040806A3
公开(公告)日:2005-07-07
申请号:PCT/EP2004011597
申请日:2004-10-15
Applicant: ROCHE DIAGNOSTICS GMBH , HOFFMANN LA ROCHE , PESTLIN GABRIELE , ANDRES HERBERT , BERNDT PETER , HAGMANN MARIE-LUISE , KARL JOHANN , LANGEN HANNO , ZOLG WERNER
Inventor: PESTLIN GABRIELE , ANDRES HERBERT , BERNDT PETER , HAGMANN MARIE-LUISE , KARL JOHANN , LANGEN HANNO , ZOLG WERNER
IPC: G01N33/574
CPC classification number: G01N33/57415
Abstract: The present invention relates to the diagnosis of breast cancer. It discloses the use of protein ASC in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring ASC in said sample. Measurement of ASC can, e.g., be used in the early detection or diagnosis of breast cancer.
Abstract translation: 本发明涉及乳腺癌的诊断。 它公开了蛋白质ASC在乳腺癌诊断中的用途。 本发明涉及一种通过测量所述样品中的ASC从个体得到的液体样品诊断乳腺癌的方法。 ASC的测量可以例如用于乳腺癌的早期检测或诊断。
-
公开(公告)号:ES2323429T3
公开(公告)日:2009-07-15
申请号:ES05820046
申请日:2005-12-22
Applicant: HOFFMANN LA ROCHE
Inventor: ANDRES HERBERT , HAGMANN MARIE-LUISE , KARL JOHANN , KUNERT URSULA , PESTLIN GABRIELE
IPC: G01N33/574
Abstract: Un procedimiento para valorar el cáncer colorrectal (CRC), in vitro, que comprende las etapas de a) la medición, en una muestra, de la concentración de proteína semejante al moteado asociado a la apoptosis que contiene un dominio de reclutamiento asociado a la caspasa (ASC), b) opcionalmente, la medición, en una muestra, de la concentración determinada de uno o más marcadores adicionales distintos del cáncer colorrectal, y c) correlacionar la concentración determinada en la etapa (a), y opcionalmente, las concentraciones determinadas en la etapa b), a la diagnosis de cáncer colorrectal, en donde, un elevado nivel de ASC, es indicativo para CRC.
-
公开(公告)号:CA2586654A1
公开(公告)日:2006-06-29
申请号:CA2586654
申请日:2005-12-22
Applicant: HOFFMANN LA ROCHE
Inventor: KARL JOHANN , HAGMANN MARIE-LUISE , ANDRES HERBERT , KUNERT URSULA , PESTLIN GABRIELE
IPC: G01N33/574
Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein ASC (apoptosis-associated speck-like protein containing a caspase-associated recruitment domain) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring ASC in said sample. Measurement of ASC can, e.g., be used in the early detection or diagnosis of colorectal cancer.
-
公开(公告)号:CA2567987A1
公开(公告)日:2005-12-29
申请号:CA2567987
申请日:2005-06-17
Applicant: HOFFMANN LA ROCHE
Inventor: BERNDT PETER , HAGMANN MARIE-LUISE , PESTLIN GABRIELE , ANDRES HERBERT , THIEROLF MICHAEL , KARL JOHANN , LANGEN HANNO , ZOLG WERNER
IPC: C12Q1/68
-
公开(公告)号:CA2586654C
公开(公告)日:2010-10-05
申请号:CA2586654
申请日:2005-12-22
Applicant: HOFFMANN LA ROCHE
Inventor: ANDRES HERBERT , HAGMANN MARIE-LUISE , KARL JOHANN , KUNERT URSULA , PESTLIN GABRIELE
IPC: G01N33/574
Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein ASC (apoptosis-associated speck-like protein containing a caspase~associated recruitment domain) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring ASC in said sample. Measurement of ASC can, e.g., be used in the early detection or diagnosis of colorectal cancer.
-
-
-
-
-
-
-
-
-